Sphere Medical Holding (LSE:SPHR) Total Inventories : £0.43 Mil (As of Dec. 2016)

View and export this data going back to 2011. Start your Free Trial

What is Sphere Medical Holding Total Inventories?

Sphere Medical Holding's total inventories for the quarter that ended in Dec. 2016 was £0.43 Mil. Sphere Medical Holding's average total inventories from the quarter that ended in Jun. 2016 to the quarter that ended in Dec. 2016 was £0.43 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Sphere Medical Holding's Net-Net Working Capital per share for the quarter that ended in Dec. 2016 was £0.02.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Sphere Medical Holding's Days Inventory for the six months ended in Dec. 2016 was 4,616.18.

Inventory Turnover measures how fast the company turns over its inventory within a year. Sphere Medical Holding's Inventory Turnover for the quarter that ended in Dec. 2016 was 0.04.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Sphere Medical Holding's Inventory-to-Revenue for the quarter that ended in Dec. 2016 was 17.92.

Sphere Medical Holding Total Inventories Historical Data

The historical data trend for Sphere Medical Holding's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sphere Medical Holding Total Inventories Chart

Sphere Medical Holding Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Total Inventories

Get a 7-Day Free Trial

0.07

0.04

0.22

0.38

0.43

Sphere Medical Holding Semi-Annual Data
	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16
Total Inventories	Get a 7-Day Free Trial						0.22	0.28	0.38	0.43	0.43

Sphere Medical Holding Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Sphere Medical Holding (LSE:SPHR) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Sphere Medical Holding's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2016 is

	Net-Net Working Capital Per Share (Q: Dec. 2016 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(3.241	+	0.75 * 0.024	+	0.5 * 0.427	-	0.757
-	0	-	0)	/	141.76
=	0.02

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Sphere Medical Holding's Days Inventory for the six months ended in Dec. 2016 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2016 )	/	Cost of Goods Sold (Q: Dec. 2016 )	*	Days in Period
	=	0.43	/	0.017	*	365 / 2
	=	4,616.18

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Sphere Medical Holding's Inventory Turnover for the quarter that ended in Dec. 2016 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2016 )	/	Average Total Inventories (Q: Dec. 2016 )
	=	0.017	/	0.43
	=	0.04

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Sphere Medical Holding's Inventory to Revenue for the quarter that ended in Dec. 2016 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2016 )	/	Revenue (Q: Dec. 2016 )
	=	0.43	/	0.024
	=	17.92

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Sphere Medical Holding Total Inventories Related Terms

Thank you for viewing the detailed overview of Sphere Medical Holding's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Sphere Medical Holding (LSE:SPHR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sphere Medical Holding PLC (LSE:SPHR) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

Harston Mill, Harston, Cambridge, GBR, CB22 7GG

Website

http://www.spheremedical.com

Sphere Medical Holding Ltd is a UK-based company which is engaged in research and development, manufacturing and sale of medical monitoring and diagnostic equipment within the medical device area. It focuses on developing the Proxima platform for measuring blood gases, electrolytes and metabolites. Proxima is an in-line patient dedicated arterial blood analyser which supports frequent measurements at critical times. It markets its product (Proxima) to critical care market which includes ICU (Intensive Care Unit) and OR (Operating Room). The company's products are used in medical applications, enabling faster clinical decision-making and improved patient outcomes. It operates is business in single reporting segment of Medical devices. Most of the company's revenue comes from Europe.